Chargement en cours...

Residual Breast Cancer Diagnosed by MRI in Patients Receiving Neoadjuvant Chemotherapy with and without Bevacizumab

PURPOSE: To investigate the impact of anti-angiogenic therapy with bevacizumab on pathological response and the diagnostic performance of MRI in breast cancer patients. METHODS: Thirty-six patients (age 31-69) with breast cancer were included. Sixteen patients received neoadjuvant chemotherapy (NAC)...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bahri, Shadfar, Chen, Jeon-Hor, Mehta, Rita S., Carpenter, Philip M., Nie, Ke, Kwon, Soon-Young, Yu, Hon J., Nalcioglu, Orhan, Su, Min-Ying
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2786305/
https://ncbi.nlm.nih.gov/pubmed/19333654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-009-0441-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!